Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.
Rockwell Medical Signs $125M M&A Deal with Vantive Limited
Rockwell Medical has entered into a definitive agreement to acquire Vantive Limited's global in-center hemodialysis business for a base purchase price of $125 million. The acquisition includes manufacturing facilities in Italy, operations in 35 jurisdictions, and a product portfolio spanning concentrates, machines, and water treatment systems. The deal is expected to transform Rockwell into a global provider with projected annual revenues between $400 million and $450 million.
Value
$125M
Counterparty
Vantive Limited
“Acquiring Vantive’s hemodialysis assets and associated operations represents a transformative step in Rockwell Medical’s evolution and directly advances the strategy we have been executing over the past several years.”
Mark Strobeck, Ph.D., President and Chief Executive Officer at Rockwell Medical
InMed Pharmaceuticals M&A Deal with Mentari Therapeutics, Inc.
InMed Pharmaceuticals provided a status update on its pending merger with Mentari Therapeutics, which is expected to close in Q4 2026. Mentari has announced private placements totaling $490 million to support operations through 2029, and InMed shareholders will vote on the transaction at a meeting on November 4, 2026.
Counterparty
Mentari Therapeutics, Inc.
“We are approaching an important milestone in our proposed merger with Mentari Therapeutics, with our annual general and special meeting scheduled for November 4, 2026. Our focus remains on completing the transaction, which we believe provides shareholders with an opportunity to participate in the development of Mentari's migraine prevention pipeline.”
H2O America completed the issuance and sale of 7,475,000 equity units, including the full exercise of the underwriters' over-allotment option, at a stated amount of $50 per unit. Each unit consists of a stock purchase contract obligating the holder to buy common stock by November 2029 and a beneficial interest in 5.300% Remarketable Senior Notes due 2031. The offering raised approximately $373.75 million in gross proceeds to be used for general corporate purposes.
WhiteFiber Signs $60M M&A Deal with Unifi Manufacturing, Inc.
WhiteFiber, Inc. completed the $60 million cash acquisition of two industrial properties in Yadkin County, North Carolina, from Unifi Manufacturing, Inc. The company intends to retrofit the 500,000 square feet of existing warehouse space into data center campuses with a potential power capacity of up to 198 megawatts. The acquisition builds on WhiteFiber's regional development strategy following its NC-1 campus in Madison, North Carolina.
Chilean Cobalt Signs $27.8M M&A Deal with NeoRe SpA
Chilean Cobalt Corp. entered into a definitive option agreement to acquire 4,281 hectares of mining concessions in the San Juan district of Chile for a total of $27.8 million in installment payments through 2028. Additionally, the company amended its existing earn-in and option agreement with NeoRe SpA regarding the NeoRe Rare Earth Project.
Liminatus Pharma entered into a subscription agreement with a non-U.S. investor for a private placement of 260,001 shares of common stock. The company raised gross proceeds of approximately $0.65 million at a price of $2.50 per share. The proceeds are intended for working capital and general corporate purposes.
Swarmer M&A Deal with Limited Liability Company Jk Land Vehicles
Swarmer, Inc. stockholders approved the issuance of up to 5,487,067 shares of common stock in connection with the acquisition of Ratel Robotics, a Ukrainian limited liability company. The issuance includes 1,064,942 shares at closing and up to 4,422,125 shares contingent upon the achievement of specific earnout targets. The approval satisfies Nasdaq requirements for the transaction originally announced in September 2026.
Counterparty
LIMITED LIABILITY COMPANY JK LAND VEHICLES (Ratel Robotics)
Profound Medical Partnership with Cook Medical Holdings LLC
Profound Medical entered into a supply and distribution agreement with Cook Medical to appoint them as a non-exclusive distributor of the TULSA-PRO system in the U.S. The partnership integrates TULSA-PRO into Cook's Copernicus program for intraoperative MRI suites, expanding Profound's sales channels while retaining direct recurring revenue from disposables and service.
MarineMax announced that all regulatory approvals and clearances have been obtained for its pending merger with affiliates of Safe Harbor Marinas (a Blackstone portfolio company). The company expects the transaction to close by the end of 2026, subject to a shareholder vote scheduled for November 11, 2026.
Real Remax Group M&A Deal with RE/MAX Holdings, Inc.
Real REMAX Group Inc. filed an amendment to its 8-K to provide historical and pro forma financial statements following its completed acquisition of RE/MAX Holdings, Inc. and The Real Brokerage Inc. The transaction, which closed on August 24, 2026, was accounted for as a business combination with Real as the accounting acquiror. The filing also details a $550 million term loan facility and a $40 million revolving credit facility used to finance the combination.
Braemar Hotels & Resorts Divestiture to Evergreen Acquisitions, LLC for $372M
Braemar Hotels & Resorts completed the sale of the 210-room Four Seasons Resort Scottsdale to Evergreen Acquisitions, LLC for $372 million in cash. The company expects to use the proceeds to fund remaining fees related to its transition to a self-managed REIT, which is on track for completion in mid-November 2026.
Salamander Innisbrook Divestiture to Concert Innisbrook, LLC and CGP Innisbrook, LLC for $19.8M
Salamander Innisbrook, LLC entered into a definitive agreement to sell the Innisbrook Resort and Golf Club, along with three condominium units, to Concert Innisbrook, LLC and CGP Innisbrook, LLC for $19.8 million in cash. The company expects to use the proceeds to repay its outstanding Truist Bank loan in full, with the transaction expected to close by December 31, 2026.
Reed's, Inc. entered into a securities purchase agreement with its majority stockholder, D&D Source of Life Holding, Ltd., for a $10.0 million private placement of 17,421,602 shares of common stock. The proceeds will be used for working capital and to satisfy a $10.0 million equity contribution requirement under the company's senior secured loan agreement.
Alphega Innovations Partnership with Maison Bouvier Inc.
Alphega Innovations Corp entered into a Strategic Cooperation Agreement with Maison Bouvier Inc. to identify and pursue M&A and strategic partnership opportunities. The parties plan to form a new subsidiary, Alphega XYZ Corp (NewCo), owned 80% by Alphega and 20% by Maison Bouvier, while Maison Bouvier committed to a $400,000 strategic investment in Alphega common stock.
Eyeonix AIQ's subsidiary, Eyeonix MedAIQ, entered into a Memorandum of Understanding to acquire the source code for the COMMAND HEALGRID software from Eyeonix Greece. In exchange for the asset, the company will issue 30,600,000 shares of its common stock to Eyeonix Greece, with the deal expected to close by the end of 2026.
DigitalOcean delivered a massive beat-and-raise quarter, accelerating revenue growth to 40% while significantly increasing 2027 guidance to 60% plus, driven by agentic AI and high-yield software-led infrastructure.
Safety Insurance Group M&A Deal with MAPFRE U.S.A. Corp.
Safety Insurance Group stockholders approved the previously announced merger agreement with MAPFRE U.S.A. Corp. at a special meeting. Under the terms of the agreement, Safety will become a wholly owned subsidiary of MAPFRE, subject to remaining customary closing conditions and regulatory approvals.
BETA Technologies delivered a record revenue beat driven by component sales and infrastructure, while securing critical FAA VTOL market survey authorization and advancing non-dilutive financing.
Fortress Net Lease REIT issued and sold 8,730,792 common shares across multiple classes for gross proceeds of approximately $93.9 million in an unregistered private placement. Additionally, the company declared monthly distributions for all share classes to shareholders of record as of October 30, 2026.
Macquarie Infrastructure Income Opportunities Fund Capital Raise of $17.6M
Macquarie Infrastructure Income Opportunities Fund sold 691,489.361 Class J common shares for $17.55 million in its October 2026 monthly closing. The shares were issued as part of a continuous private offering at a price of $25.38 per share, which was the Fund's NAV as of September 30, 2026.
Kairos Pharma, Ltd. entered into a third amendment to its existing equity line of credit (ELOC) purchase agreement with Helena Global Investment Opportunities I Ltd. The amendment extends the company's option to use the ELOC for an additional year until December 31, 2028, and follows previous amendments that adjusted the purchase price to 97% of VWAP and shortened the pricing period.
Bread Financial Holdings issued and sold 5,000,000 depositary shares, each representing a 1/40th interest in its new 9.375% Series C Non-Cumulative Perpetual Preferred Stock. The company also granted underwriters a 30-day option to purchase up to an additional 750,000 depositary shares. The issuance includes restrictions on junior stock dividends and repurchases if preferred dividends are not paid.
Kennedy Lewis Capital Company reported that it has raised approximately $780.5 million in total consideration through its continuous public offering and private placement as of October 1, 2026. The company also disclosed a net asset value (NAV) per share of $19.68 for Class I and Class D shares and $19.65 for Class S shares as of September 30, 2026.
Hawthorn Bancshares M&A Deal with FSC Bancshares, Inc.
Hawthorn Bancshares, Inc. filed an amendment to its previous 8-K to provide required financial statements and pro forma information following the completion of its acquisition of FSC Bancshares, Inc. The acquisition was effective as of September 3, 2026, and this filing includes audited 2025 financial statements for the acquired entity.
Impact Biomedical Inc. announced that the SEC has declared effective the Form F-4 registration statement for its proposed merger with Zoar Limited. A special meeting of stockholders to approve the business combination is scheduled for November 13, 2026, with the combined company expected to trade under the ticker symbol 'ZOAR'.
SurgePays Wins $48M Contract from Zulie Venture Inc.
SurgePays entered into a material prepaid wireless purchase commitment with Etime system, which operates a payments network of over 1,000 retail locations. Etime system has committed to purchase at least $4 million in prepaid wireless airtime and top-up transactions monthly, totaling a minimum of $48 million over the initial one-year term.
AEON Biopharma entered into a warrant amendment to reduce the exercise price of its outstanding two-year milestone warrants from $0.3221 to $0.20 per share. Certain holders have agreed to exercise their warrants at this reduced price, which is expected to generate approximately $6.2 million in gross proceeds for the company. The warrants were triggered for accelerated expiration following FDA feedback on the company's ABP-450 biosimilar pathway and will expire on November 16, 2026.
Viking Global Technologies' subsidiary, Viking Ozone Technology, received formal Attestation of Conformity No. 41506-0 from the French regulator LNE for its VKIN-300 medical waste pretreatment system. The approval confirms the ozone-based disinfection technology complies with French Standard NF X 30-503-1:2024, enabling commercialization of the system in France through October 2031.
Counterparty
Laboratoire national de métrologie et d'essais (LNE)
OppFi Inc. announced the withdrawal of its regulatory applications with the OCC, Federal Reserve, and FDIC regarding its proposed acquisition of BNCCORP, Inc. and BNC National Bank. While the applications were withdrawn due to a lack of clear regulatory standards for fintech-bank combinations, the merger agreement remains in effect as of the filing date.
Peraso Inc. completed a $4.0 million private placement with Nant Capital, LLC, issuing 3,271,355 shares of common stock and pre-funded warrants. The company also entered into a registration rights agreement requiring it to file a resale registration statement for the shares and warrant shares by November 27, 2026.